In this context, we recently reported that calpain inhibition increases the SMN protein level in cultured spinal cord MNs and that administration of calpeptin (a well-known calpain inhibitor) to SMA mice models improves lifespan and motor function21. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.